Two New Treatments for Gonorrhea; one is available now!
In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of urogenital gonorrhea. The episode highlights th...
12 Tammi 15min
PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned
On June 18, 2025, the FDA approved Yeztugo, the brand name for subcutaneous lenacapavir, a prescription medication used for the pre-exposure prophylaxis of HIV. Subcutaneous lenacapavir is administer...
20 Marras 202528min
Keeping an Eye on STIs – Have You Heard of TMVII?
This month, host Dr. Marguerite Urban chats with Dr. Jason Zucker, an adult and pediatric infectious diseases physician at Columbia University and the assistant medical director of the New York City H...
13 Marras 202518min
Recap of the 2025 Annual New York State Hepatitis C and Drug User Health Conference
On September 9th, CEI hosted its first in-person conference dedicated to hepatitis C and drug user health. A group of New York State-based clinicians met in Catskill for a full day agenda focused on (...
9 Loka 202527min
Insights from the 13th International AIDS Society Conference on HIV Science
In this episode of Conversations with CEI, Dr. Steven Fine unpacks some of the latest developments and research presented at the 2025 International AIDS Society (IAS) Conference on HIV Science, held i...
9 Syys 202516min
Evolving Landscape of Geriatric HIV Care
The demographics of HIV care are rapidly changing, and with them, the clinical needs of patients aging with HIV. In this episode, host Dr. Tony Urbina, Medical Director for CEI's HIV Primary Care and ...
11 Elo 202527min
Xylazine & Medetomidine & Nitazines, Oh My! An Update on New York State’s Drug Supply
New York drug overdose deaths and death rates are on the decline, but with significant disparities and the current, toxic drug supply is partially to blame. Harmful additives like fentanyl analogues, ...
12 Kesä 202529min
